Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
23S ribosomal RNA is a large RNA molecule, approximately 2,904 nucleotides in *Escherichia coli*, forming the catalytic core (peptidyl transferase center) of the 50S subunit of the bacterial ribosome[1][2]. It is essential for protein synthesis, facilitating peptide bond formation and ensuring proper positioning of tRNAs during translation[1][9][3]. The 23S rRNA is organized into six secondary structural domains, serving as the primary site for the binding of many clinically important antibiotics that inhibit bacterial translation[1]. Mutations or chemical modifications in specific nucleotides of 23S rRNA can result in antibiotic resistance and affect bacterial fitness[1][7]. The eukaryotic homolog is the 28S rRNA found in the 60S ribosomal subunit[1].
Inhibition of peptide bond formation by binding to the peptidyl transferase center Prevention of tRNA binding or proper positioning Inhibition of ribosomal translocation or elongation during translation Induction of conformational changes that hinder ribosomal function
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 23S ribosomal RNA of the 50S bacterial ribosome subunit (23S rRNA).